These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Electroconvulsive therapy for malignant catatonia in adolescence. Dhossche DM; Shettar SM; Kumar T; Burt L South Med J; 2009 Nov; 102(11):1170-2. PubMed ID: 19864990 [TBL] [Abstract][Full Text] [Related]
24. Catatonia in autistic spectrum disorders: a medical treatment algorithm. Fink M; Taylor MA; Ghaziuddin N Int Rev Neurobiol; 2006; 72():233-44. PubMed ID: 16697301 [TBL] [Abstract][Full Text] [Related]
25. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. Carroll BT; Goforth HW; Thomas C; Ahuja N; McDaniel WW; Kraus MF; Spiegel DR; Franco KN; Pozuelo L; Muñoz C J Neuropsychiatry Clin Neurosci; 2007; 19(4):406-12. PubMed ID: 18070843 [TBL] [Abstract][Full Text] [Related]
26. The syndrome of lethal catatonia. Tang CP; Leung CM; Ungvari GS; Leung WK Singapore Med J; 1995 Aug; 36(4):400-2. PubMed ID: 8919156 [TBL] [Abstract][Full Text] [Related]
27. Pregnancy and malignant catatonia. Espínola-Nadurille M; Ramírez-Bermúdez J; Fricchione GL Gen Hosp Psychiatry; 2007; 29(1):69-71. PubMed ID: 17189750 [TBL] [Abstract][Full Text] [Related]
28. Benzodiazepines in the treatment of catatonic syndrome. Ungvari GS; Leung CM; Wong MK; Lau J Acta Psychiatr Scand; 1994 Apr; 89(4):285-8. PubMed ID: 8023696 [TBL] [Abstract][Full Text] [Related]
29. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. Hatta K; Miyakawa K; Ota T; Usui C; Nakamura H; Arai H J ECT; 2007 Dec; 23(4):233-5. PubMed ID: 18090694 [TBL] [Abstract][Full Text] [Related]
30. Chronic 'speech catatonia' with constant logorrhea, verbigeration and echolalia successfully treated with lorazepam: a case report. Lee JW Psychiatry Clin Neurosci; 2004 Dec; 58(6):666-8. PubMed ID: 15601393 [TBL] [Abstract][Full Text] [Related]
31. Westphal variant Huntington disease and refractory catatonia: a case report. Merida-Puga J; Ramirez-Bermudez J; Aguilar-Venegas LC; Fricchione GL; Espinola-Nadurille M Cogn Behav Neurol; 2011 Dec; 24(4):204-8. PubMed ID: 22123587 [TBL] [Abstract][Full Text] [Related]
32. Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy. Utumi Y; Iseki E; Arai H Psychogeriatrics; 2013 Dec; 13(4):254-9. PubMed ID: 24164753 [TBL] [Abstract][Full Text] [Related]
34. Treatment-refractory catatonia, ECT, and parenteral lorazepam. Koek RJ; Mervis JR Am J Psychiatry; 1999 Jan; 156(1):160-1; author reply 161. PubMed ID: 9892323 [No Abstract] [Full Text] [Related]
35. Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn. Aloysi AS; Popeo DM; Kellner CH J ECT; 2011 Sep; 27(3):259-61. PubMed ID: 21206370 [TBL] [Abstract][Full Text] [Related]
36. Amisulpride Augmentation in Acute Catatonia. Arora M; Banal R; Praharaj SK; Mahajan V Am J Ther; 2017; 24(4):e381-e385. PubMed ID: 26270797 [TBL] [Abstract][Full Text] [Related]
37. Catatonia recognition and treatment. Cottencin O; Danel T; Goudemand M; Thomas P; Consoli SM Med Sci Monit; 2009 Aug; 15(8):CS129-31. PubMed ID: 19644424 [TBL] [Abstract][Full Text] [Related]
38. Parenteral lorazepam's unavailability in Australia and the impact for catatonic patients. Low DA; Xu J; Tibrewal P; Bastiampillai T; Dhillon R Aust N Z J Psychiatry; 2017 Feb; 51(2):198. PubMed ID: 27389064 [No Abstract] [Full Text] [Related]
39. [Autism and catatonia: successful treatment using lorazepam. A case study]. de Winter CF; van Dijk F; Verhoeven WM; Dhossche DM; Stolker JJ Tijdschr Psychiatr; 2007; 49(4):257-61. PubMed ID: 17436212 [TBL] [Abstract][Full Text] [Related]
40. Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy. Unal A; Bulbul F; Alpak G; Virit O; Copoglu US; Savas HA J ECT; 2013 Sep; 29(3):206-9. PubMed ID: 23965606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]